Sodium iodide i-131
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
273 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 7 | 22 | 9 | 1 | 23 | 58 |
| Thyroid diseases | D013959 | — | E00-E07 | 4 | 16 | 4 | 1 | 14 | 36 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 3 | 1 | — | 4 |
| Hypothyroidism | D007037 | EFO_0004705 | E03.9 | 1 | — | 1 | 1 | 1 | 4 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | 2 | — | 2 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | 1 | 1 | — | 2 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | — | — | 1 | — | 1 |
| Sars-cov-2 | D000086402 | — | — | — | — | — | 1 | — | 1 |
| Coronavirus | D017934 | — | — | — | — | — | 1 | — | 1 |
| Viral load | D019562 | — | — | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 12 | 32 | 4 | — | 5 | 50 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 24 | 5 | — | 5 | 44 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 13 | 13 | 3 | — | 10 | 38 |
| Papillary thyroid cancer | D000077273 | — | — | 4 | 9 | 1 | — | 2 | 15 |
| Recurrence | D012008 | — | — | 7 | 4 | 1 | — | 2 | 13 |
| Follicular adenocarcinoma | D018263 | — | — | 3 | 8 | 1 | — | — | 11 |
| Follicular lymphoma | D008224 | — | C82 | 3 | 7 | 2 | — | — | 11 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 5 | 2 | — | — | 9 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 3 | 3 | 1 | — | 3 | 9 |
| Leukemia | D007938 | — | C95 | 2 | 5 | 2 | — | — | 8 |
Show 24 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 14 | 12 | — | — | 1 | 21 |
| Central nervous system neoplasms | D016543 | — | — | 7 | 5 | — | — | 3 | 13 |
| Pheochromocytoma | D010673 | — | — | 3 | 4 | — | — | 7 | 13 |
| Carcinoma | D002277 | — | C80.0 | 2 | 6 | — | — | 3 | 10 |
| Nervous system neoplasms | D009423 | — | — | 7 | 4 | — | — | 1 | 10 |
| Paraganglioma | D010235 | — | — | 3 | 2 | — | — | 4 | 8 |
| Papillary carcinoma | D002291 | — | — | 1 | 6 | — | — | 1 | 7 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 2 | 6 | — | — | — | 7 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 3 | 4 | — | — | — | 6 |
| Multiple myeloma | D009101 | — | C90.0 | 4 | 3 | — | — | — | 6 |
Show 57 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 7 | — | — | — | — | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | — | — | — | — | 4 |
| T-cell lymphoma | D016399 | — | — | 3 | — | — | — | — | 3 |
| Syndrome | D013577 | — | — | 1 | — | — | — | 2 | 3 |
| Triple negative breast neoplasms | D064726 | — | — | 3 | — | — | — | — | 3 |
| T-cell lymphoma peripheral | D016411 | — | — | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | 1 | 2 |
| Ewing sarcoma | D012512 | EFO_0000173 | — | 1 | — | — | — | 1 | 2 |
| Rhabdomyosarcoma | D012208 | — | — | 1 | — | — | — | 1 | 2 |
Show 37 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | — | — | — | 5 | 5 |
| Tachycardia | D013610 | — | R00.0 | — | — | — | — | 4 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 4 | 4 |
| Orthostatic intolerance | D054971 | — | — | — | — | — | — | 3 | 3 |
| Xerostomia | D014987 | — | K11.7 | — | — | — | — | 2 | 2 |
| Hypovolemia | D020896 | — | E86 | — | — | — | — | 1 | 1 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 1 | 1 |
| Primary dysautonomias | D054969 | — | — | — | — | — | — | 1 | 1 |
Show 18 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
8,637 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use